Fortress Biotech (FBIO) Competitors $2.80 -0.11 (-3.78%) Closing price 10/9/2025 04:00 PM EasternExtended Trading$2.79 -0.01 (-0.39%) As of 10/9/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock FBIO vs. XOMA, VNDA, CBIO, IRWD, CDXS, SGMO, ACHV, AGEN, DOMH, and CRISShould you be buying Fortress Biotech stock or one of its competitors? The main competitors of Fortress Biotech include XOMA Royalty (XOMA), Vanda Pharmaceuticals (VNDA), Crescent Biopharma (CBIO), Ironwood Pharmaceuticals (IRWD), Codexis (CDXS), Sangamo Therapeutics (SGMO), Achieve Life Sciences (ACHV), Agenus (AGEN), Dominari (DOMH), and Curis (CRIS). These companies are all part of the "biotechnology" industry. Fortress Biotech vs. Its Competitors XOMA Royalty Vanda Pharmaceuticals Crescent Biopharma Ironwood Pharmaceuticals Codexis Sangamo Therapeutics Achieve Life Sciences Agenus Dominari Curis Fortress Biotech (NASDAQ:FBIO) and XOMA Royalty (NASDAQ:XOMA) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, media sentiment, valuation, earnings, institutional ownership and dividends. Does the media refer more to FBIO or XOMA? In the previous week, XOMA Royalty had 1 more articles in the media than Fortress Biotech. MarketBeat recorded 6 mentions for XOMA Royalty and 5 mentions for Fortress Biotech. Fortress Biotech's average media sentiment score of 0.40 beat XOMA Royalty's score of 0.23 indicating that Fortress Biotech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fortress Biotech 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral XOMA Royalty 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Which has more volatility & risk, FBIO or XOMA? Fortress Biotech has a beta of 1.75, suggesting that its share price is 75% more volatile than the S&P 500. Comparatively, XOMA Royalty has a beta of 1.02, suggesting that its share price is 2% more volatile than the S&P 500. Is FBIO or XOMA more profitable? Fortress Biotech has a net margin of -24.84% compared to XOMA Royalty's net margin of -27.57%. XOMA Royalty's return on equity of 2.63% beat Fortress Biotech's return on equity.Company Net Margins Return on Equity Return on Assets Fortress Biotech-24.84% -301.81% -27.48% XOMA Royalty -27.57%2.63%0.97% Which has preferable valuation and earnings, FBIO or XOMA? XOMA Royalty has lower revenue, but higher earnings than Fortress Biotech. XOMA Royalty is trading at a lower price-to-earnings ratio than Fortress Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFortress Biotech$57.67M1.44-$46M-$1.05-2.67XOMA Royalty$28.49M16.45-$13.82M-$1.55-25.01 Do insiders & institutionals have more ownership in FBIO or XOMA? 96.5% of Fortress Biotech shares are owned by institutional investors. Comparatively, 95.9% of XOMA Royalty shares are owned by institutional investors. 27.9% of Fortress Biotech shares are owned by insiders. Comparatively, 9.1% of XOMA Royalty shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Do analysts prefer FBIO or XOMA? Fortress Biotech currently has a consensus target price of $16.50, indicating a potential upside of 489.29%. XOMA Royalty has a consensus target price of $69.50, indicating a potential upside of 79.26%. Given Fortress Biotech's higher possible upside, analysts plainly believe Fortress Biotech is more favorable than XOMA Royalty.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fortress Biotech 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33XOMA Royalty 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.75 SummaryFortress Biotech beats XOMA Royalty on 9 of the 16 factors compared between the two stocks. Get Fortress Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for FBIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FBIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FBIO vs. The Competition Export to ExcelMetricFortress BiotechMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$86.59M$3.36B$6.14B$10.64BDividend YieldN/A2.29%5.66%4.69%P/E Ratio-2.6721.3485.7227.64Price / Sales1.44487.79631.45142.60Price / CashN/A47.1938.3262.20Price / Book-46.6710.4313.096.79Net Income-$46M-$52.40M$3.30B$275.88M7 Day Performance1.82%4.97%3.75%1.84%1 Month Performance-27.46%17.02%10.73%8.84%1 Year Performance77.22%34.38%85.28%36.10% Fortress Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FBIOFortress Biotech2.5823 of 5 stars$2.80-3.8%$16.50+489.3%+77.2%$86.59M$57.67M-2.67170Analyst ForecastXOMAXOMA Royalty4.1095 of 5 stars$37.20+1.4%$69.50+86.8%+42.0%$443.39M$12.77M-24.0010Analyst ForecastVNDAVanda Pharmaceuticals4.1081 of 5 stars$4.91-3.7%$16.50+236.0%+21.9%$301.35M$203.47M-4.35290Analyst ForecastCBIOCrescent Biopharma4.399 of 5 stars$12.29-1.1%$25.60+108.3%N/A$243M$10K-0.3550Positive NewsIRWDIronwood Pharmaceuticals4.4821 of 5 stars$1.42+2.2%$4.94+247.9%-58.0%$225.78M$351.41M-28.39220Positive NewsAnalyst ForecastCDXSCodexis3.0818 of 5 stars$2.46flat$11.00+347.2%-13.3%$222.06M$59.35M-2.96250Positive NewsAnalyst ForecastSGMOSangamo Therapeutics2.214 of 5 stars$0.70+5.4%$4.50+542.9%-6.5%$200.34M$57.80M-2.41480News CoverageAnalyst ForecastHigh Trading VolumeACHVAchieve Life Sciences2.7663 of 5 stars$3.04+1.0%$12.00+294.7%-35.9%$153.83MN/A-2.0820Analyst ForecastAGENAgenus4.3882 of 5 stars$3.98+0.8%$14.50+264.3%-8.6%$125.86M$103.46M-0.56440Analyst ForecastDOMHDominari0.6317 of 5 stars$7.25+6.0%N/A+237.0%$106.32M$52.81M-3.064News CoverageAnalyst ForecastCRISCuris2.2323 of 5 stars$1.66-1.8%$17.00+924.1%-68.1%$21.12M$10.91M-0.3460Positive NewsAnalyst ForecastHigh Trading Volume Related Companies and Tools Related Companies XOMA Alternatives VNDA Alternatives CBIO Alternatives IRWD Alternatives CDXS Alternatives SGMO Alternatives ACHV Alternatives AGEN Alternatives DOMH Alternatives CRIS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FBIO) was last updated on 10/10/2025 by MarketBeat.com Staff From Our Partners"I'm risking my reputation on this"The Fed rate cut truth they don't want you to know The Fed's 25 basis point cut isn't just monetary policy…...Crypto 101 Media | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredElon callingElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredTrump to get REVENGE on the banks??Rumors are swirling that Trump could target the banking system by upending the $5 trillion-a-day SWIFT network...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortress Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fortress Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
